interferons in the treatment of mpns: clinical trials in 2021
Published 3 years ago • 162 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
1:27
the use of interferons in the treatment of mpns
-
1:10
the treatment schedule for interferon therapy in patients with pv
-
1:44
the role of interferon in the treatment of accelerated/blast phase mpn
-
15:45
updates on the use of ropeginterferon in the treatment of mpns
-
1:41
updates on ropeginterferon in mpns
-
1:29
changing attitudes to using interferon in pediatric patients with mpns
-
4:36
haemonetics
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
3:12
diagnosed early in life with polycythemia vera: todd’s mpn story
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
1:51
checkpoint inhibition in the treatment of mpns
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:45
deciding which patients with mpns are suitable candidates for interferon-based therapy
-
1:19
what's on the horizon for the treatment of mpns?
-
0:55
best use practices for clinicians prescribing interferon to patients with mpns
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
1:43
factors predicting durable remission after ifn therapy discontinuation in mpn patients
-
1:58
unmet needs in sr-agvhd and tr-agvhd
-
0:29
interferon-γ signaling contributes to drug resistance in aml
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment